Douglas B Given's Net Worth

$8.91 Million

Estimate Recalculated Jul 3, 2024 04:29PM EST

Who is Douglas B Given?

Douglas B Given has an estimated net worth of $8.91 Million. This is based on reported shares across multiple companies, which include ARROWHEAD PHARMACEUTICALS, INC., VIA Pharmaceuticals, Inc., and AKSYS LTD.

SEC CIK

Douglas B Given's CIK is 0001156207

Past Insider Trading and Trends

2019 was Douglas B Given's most active year for acquiring shares with 5 total transactions. Douglas B Given's most active month to acquire stocks was the month of December. 2020 was Douglas B Given's most active year for disposing of shares, totalling 14 transactions. Douglas B Given's most active month to dispose stocks was the month of November. 2019 saw Douglas B Given paying a total of $254,570.00 for 101,000 shares, this is the most they've acquired in one year. In 2019 Douglas B Given cashed out on 136,000 shares for a total of $1,346,140.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $31.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.19%
-2.91K
$38.06
-$110,788.36
129.71K
Scheduled
Jan 11
Form 4
+12.74%
14.99K
$25.41
$380,819.67
132.62K
Dec 15
Form 4
-5.24%
-6.50K
$40.90
-$265,850.00
117.64K
May 5
Form 4
-6.31%
-875.00
$32.62
-$28,542.50
13K
Feb 27
Form 4
+6.77%
7.87K
—
—
124.14K
Jan 10
Form 4
+5.83%
6.4K
—
—
116.27K
Jan 7
Form 4
—
0
$66.37
$43,472.35
109.87K
Dec 28
Form 4
-4.35%
-5.00K
$65.24
-$326,200.00
109.87K
Sep 9
Form 4
-3.77%
-4.50K
$89.21
-$401,445.00
114.87K
Jun 22
Form 4
-7.50%
-1.13K
$88.73
-$99,821.25
13.88K
Feb 22
Form 4
-19.35%
-3.00K
$83.28
-$249,840.00
12.5K
Jan 15
Form 4
+4.83%
5.5K
$76.08
-$304,320.00
119.37K
Jan 1 - Jan 4
Form 4
-0.76%
-870.00
—
—
113.87K
Dec 17 - Dec 22
Form 4
-6.18%
-9.57K
$79.44
-$759,442.50
145.24K
Dec 7 - Dec 17
Form 4
-14.43%
-26.11K
$36.89
-$922,250.00
154.81K
Apr 14
Form 4
+4.63%
8K
—
—
180.93K
Jan 1
Form 4
-1.68%
-3.00K
$11.56
-$1,050,830.00
175.13K
Scheduled
Feb 22 - Feb 26
Form 4
-1.66%
-3.00K
$13.58
-$40,740.00
178.13K
Scheduled
Jan 22
Form 4
+24.81%
36K
—
—
181.13K
Jan 1
Form 4
-2.03%
-3.00K
$12.00
-$36,000.00
145.13K
Scheduled
Dec 27
Form 4
-1.99%
-3.00K
$12.74
-$38,220.00
148.13K
Scheduled
Nov 23
Form 4
-2.50%
-3.87K
—
—
151.13K
Oct 22
Form 4
-13.89%
-25.00K
$6.63
-$165,750.00
155K
Scheduled
Apr 24
Form 4
+20.00%
30K
—
—
180K
Jan 1
Form 4
+114.29%
80K
—
—
150K
Jan 1
Form 4
-22.22%
-20.00K
$6.72
-$80,640.00
70K
Jan 12 - Oct 14
Form 4
+63.64%
35K
—
—
90K
Jan 1
Form 4
+175.00%
35K
—
—
55K
Mar 4
Form 4
—
0
$8.72
-$26,100.00
20K
Scheduled
Sep 26
Form 4
—
0
$7.96
-$59,450.50
20K
Aug 15
Form 4
∞
20K
—
—
20K
Feb 6
Form 4
—
0
—
—
0
Sep 21
Form 4
—
0
—
—
0
May 6
Form 4/A
—
0
—
—
0
Mar 21
Form 4
—
0
—
—
0
Mar 21
Form 4
—
0
—
—
0
Sep 28
Form 3
—
0
—
—
0
No matching records found

VIA Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Mar 26
Form 4
—
0
—
—
0
Mar 12
Form 4
∞
122.87K
—
—
122.87K
Jun 5
Form 3
—
0
—
—
0
No matching records found

AKSYS LTD No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Jun 23
Form 3
—
0
—
—
0
No matching records found